Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: (media or consultation) and vaccines
2012
PHARMAC documents that matched your search:
Proposal to amend the listing applying to the diphtheria, pertussis and tetanus vaccine (Boostrix); Closing Date: Closed; Contact: Greg Williams
(3 pages, 117 KB)
2012/11/14
“14 November 2012 Proposal to amend the listing applying to the diphtheria, pertussis and tetanus”
14 November 2012 Proposal to amend the listing applying to the diphtheria, pertussis and tetanus vaccine (Boostrix) PHARMAC is seeking feedback on a proposal to amend access to the combination diphtheria, pertussis and tetanus vaccine (under the brand name Boostrix)…
Decision to amend the diphtheria, pertussis and tetanus vaccine (Boostrix) listing; Contact: Notifications; Posted: 2012-12-12
(3 pages, 108 KB)
2012/12/12
“vaccine (under the brand name Boostrix) from 1 January 2013. The consultation document in relation”
12 December 2012 Decision to amend the diphtheria, pertussis and tetanus vaccine (Boostrix) listing PHARMAC is pleased to announce the approval of a proposal to amend the criteria for accessing funding for the combination diphtheria, pertussis and tetanus vaccine (under…
2012-09 Clinicians Newsletter
(4 pages, 386 KB)
2012/09/25
“consultation that will lead to the development of a national list of preferred medicines to be used in our public hospitals. Management of vaccines”
Pharmaceutical Management Agency Clinicians’ “Make life easier, always think generically” Newsletter August - September 2012 Blood glucose test strips and meters The acceptance of the proposal to fund CareSens blood glucose systems as the sole funded brand of meters and…
2012-10 Clinicians Newsletter
(3 pages, 470 KB)
2012/10/24
“consultation that will lead to the development of a national list of preferred medicines to be used in our public hospitals. Management of vaccines”
Pharmaceutical Management Agency Clinicians’ “Make life easier, always think generically” Newsletter October 2012 Online resources We now have a range of resources on a variety of topics including diabetes. These can be accessed via www.pharmaconline.co.nz. Other diabetes resources available online…
Inpharmation: September 2012
(4 pages, 407 KB)
2012/09/13
“consultation that will lead to the development of a national list of preferred medicines to be used in our public hospitals. Management of vaccines”
Pharmaceutical Management Agency September 2012 “Our model for managing community medicines has been successful in growing New Zealanders’ access to funded medicines, while keeping spending within budget” From the Chief Executive I am very pleased to be able to lead…
PHARMAC's OPP review: Next steps
(4 pages, 269 KB)
2012/12/03
“Consultation (current OPP section 4.2) 3.2. Communications 3.3. Consumer Advisory Committee (current OPP section 1.5.1) 3.4. Feedback 4. Submitting an application 4.1. Pharmaceuticals (community, hospital and vaccines”
PHARMAC’S Operating Policies and Procedures review Next steps PHARMAC’s Operating Policies and Procedures (OPP) outline how we go about fulfilling our statutory objective and other key functions. The OPP is intended to help our stakeholders know what to expect when…
Statement of Intent 2012/13-2014/15
(42 pages, 1173 KB)
2012/07/18
“media. During 2010/11 PHARMAC was given greater responsibility to begin assuming responsibility for purchasing medical devices (see box panel P20) and this work is likely to grow in consultation with other health sector agencies. PHARMAC”
Pharmaceutical Management Agency Statement of Intent 2012/13 – 2014/15 PHARMAC Statement of Intent 2012/13—2014/15 PHARMAC Statement of Intent 2012/13-2014/15 i INTRODUCTION PHARMAC has been successful in its core role of making decisions on behalf of District Health Boards (DHBs) about…
Proposal Relating to the Funding of Certain Pharmaceuticals in DHB Hospitals and in the Community; Closing Date: Closed; Contact: Sean Dougherty
(25 pages, 285 KB)
2012/11/19
“consultations relevant to this work are available on PHARMAC’s website: www.pharmac.govt.nz/HospitalPharmaceuticals We expect to seek feedback on the fourth and final section in late February, which will include pharmaceuticals relating to haematology, oncology”
19 November 2012 Proposal Relating to the Funding of Certain Pharmaceuticals in DHB Hospitals and in the Community PHARMAC is seeking feedback on a proposal relating to the establishment of a nationallyconsistent list of pharmaceuticals to be funded within DHB…
Summary of responses to blood glucose meters and test strips consultation
(31 pages, 203 KB)
2012/08/08
“media (i.e. YouTube videos) and consumer networks will support any implementation. C, P, PG PHARMAC note that any proposed implementation plan would have to be modified and adapted to particular stakeholder groups and this”
Analysis of issued raised in consultation Blood glucose meters and test strips June 2012 Executive Summary This summary of submissions outlines the key themes from the 2645 submissions received on the consultation document ‘Proposals relating to multiple diabetes products’ dated…
Pharmaceutical Schedule - effective 1 December 2012
(234 pages, 1495 KB)
2012/11/27
“consultation. For the purposes of the definition it makes no difference whether or not the Specialist is employed by a hospital. “Hospital Pharmacy-Specialist Prescription” means that the Community Pharmaceutical is not eligible for Subsidy”
Pharmaceutical Management Agency December 2012 New Zealand Pharmaceutical Schedule December 2012 Volume 19 Number 3 Editors: Kaye Wilson, Donna Jennings & Sarah Le Leu email: schedule@pharmac.govt.nz Telephone +64 4 460 4990 Facsimile +64 4 460 4995 Level 9, 40 Mercer…
